320
Participants
Start Date
May 31, 2003
Primary Completion Date
November 30, 2006
Study Completion Date
November 30, 2006
Levonorgestrel/EE 0.15/0.03 mg and EE 0.01 mg tablets
1 tablet daily
Duramed Investigational Site, Rochester
Duramed Investigational Site, Washington D.C.
Duramed Investigational Site, Arlington
Duramed Investigational Site, Norfolk
Duramed Investigational Site, Winston-Salem
Duramed Investigational Site, Charlotte
Duramed Investigational Site, Nashville
Duramed Investigational Site, Columbus
Duramed Investigational Site, Lincoln
Duramed Investigational Site, Oklahoma City
Duramed Investigational Site, Tucson
Lead Sponsor
Duramed Research
INDUSTRY